Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for prevention of ipilimumab-induced diarrhea in advanced melanoma
NCT00135408Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2005
- Primary completion
- Jul 2007
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of EPI-EE in diarrhea, sponsored by Bristol Myers Squibb. Started Dec 2005; status: completed.
02
Drugs
EPI-EE
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT00135408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135408.